Molecular Pathology Lab
Make Perfectly
Make Professionally
Masterpiece in Pharmaceutical industry
Make Perfectly
Make Professionally
Masterpiece in Pharmaceutical industry
Previous slide
Next slide
Welcome to Molecular Pathology Lab
Our laboratory is dedicated to comprehensively understanding the mechanisms of cancer development, identifying and validating cancer target genes, and developing innovative biomarkers and antibody-based therapy rooted in molecular biology. Our primary research areas encompass biomarker discovery, Antibody based therapeutics, Cell based therapy and so on.
Faculty
Shin, Young Kee
Professor
Hong, Sung Youl
Research professor
Chaithanya Chelakkot
Research professor
Guillen Quispe Yanymee Nimesia
research professor
Recent Articles
Peripheral immune profiling identifies CD8⁺ TEMRA and CD4⁺ T TIGIT⁺ cells as independent prognostic markers for first-line immune checkpoint inhibitors in advanced non-small cell lung cancer.
Jieun Park, Juwhan Choi, Seunghun Lee, Chae Rin Kim, Yeonwoo Lee, Jihyun Park, Yulim Lee, Young Kee Shin & Sung Yong Lee.
2026
Respiratory Research
An Ant-Inspired Dielectric Elastomer Soft Robot With Unequal Biaxial Pre-Stretching for Fast Locomotion and Versatile Applications.
He Yu, Changyunkun Xiao, Tianyi Duan, Yuqing Yang, Youngkee Shin, Kunpeng Li, Eunseong Kim, Namyoung Kim, Yang Li.
2026
Advanced Functional Materials
Molecular basis for a pore block of Tentonin 3 expressed in HEK293 cells by a conopeptide, NMB-1
Sujin Lim, Junhyuk Woo, Sungmin Pak, Joonho Paik, Gyu-Sang Hong, Ji Hun Wi, Sanghee Lee, Cristina Fenollar-Ferrer, Kyungreem Han, Young Kee Shin, Uhtaek Oh
2026
British Journal of Pharmacology
Prognostic impact of sarcopenia and blood biomarkers in advanced non-small cell lung cancer on first-line immune checkpoint inhibitors
Jieun Park, Juwhan Choi, Seunghun Lee, Jihyun Park , Chae Rinim, Yeonwoo Lee, Yulim Lee, Young Kee Shin & Sung Yong Lee.
2026
Scientific Reports
Bulletin Board
-
2026-03-20
-
2026-03-20
-
2025-01-31
-
2025-01-21
-
2025-01-21




